MHRA alert Archives | Dispensing Doctors' Association

December 5th 2023

Caramet 25/100mg CR Tablets labelling error

API unaffected Teva UK Limited has advised a labelling error on Caramet 25/100mg CR Tablets. The affected batch Batch Number Expiry Date Pack Size First Distributed 23043965 Jan 2027 60 tablets 28 June 2023 incorrectly s

November 30th 2023

Fluenz Tetra nasal spray suspension recall

Expiry dates to be advanced by up to five days Six batches of Fluenz Tetra nasal spray suspension are being recalled. This is due to stability testing that suggests the need to reduce stated expiry dates by up to five days. Amended expiry dates ar

October 23rd 2023

Falsely labelled semaglutide pens identified

No evidence of supply to patients Pre-filled pens falsely labelled as the diabetes medicine Ozempic (semaglutide, 1 mg, solution for injection) have been identified at two UK wholesalers. All affected pens have been recalled and accounted for, and

Hot topics

DM Zone news HR Zone news Clinical guidance news Political News Scotland Wales Rurality Supply Shortages COVID19

September 21st 2023

Trimbow 87/5/9 mcg pressurised inhalation solution recall

Delivery uniformity concerns Chiesi Ltd is recalling two batches of Trimbow 87/5/9 mcg pressurised inhalation solution. The affected batches are: Batch Number Expiry Date Pack Size First Distributed 1165031 18/09/2024 1 contain

September 4th 2023

Various MHRA safety alerts

Three affected products MHRA has issued various safety alerts: Class 2: Veriton Pharma Limited, Epistatus 2.5 mg oromucosal solution, pre-filled syringe (Veriton Pharma Limited) One affected batch is being recalled: Batch Number Expi

August 25th 2023

Olmesartan Medoxomil 10mg and 20mg PIL error

Missing safety information Accord Healthcare Limited, UK is advising of a PIL error in certain batches of Olmesartan Medoxomil 10mg and 20mg film coated tablets: Olmesartan Medoxomil 10mg film coated tablets Batch No Expiry Date

July 25th 2023

Hyoscine hydrobromide patches drug safety update

Anticholinergic side effects The MHRA has published a Drug Safety Update about hyoscine hydrobromide patches (Scopoderm 1.5 mg Patch or Scopoderm TTS Patch. There have been a small number of reports of serious and life-threatening an